InvestorsHub Logo
Followers 79
Posts 24525
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 12/06/2017 8:06:04 AM

Wednesday, December 06, 2017 8:06:04 AM

Post# of 27432
CLRB - 1.21 Pre-market now at 1.57/1.69

Cellectar Announces Expansion of Relapsed/Refractory Multiple Myeloma Cohort in Phase 2 Trial of CLR 131



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.